Caribou Biosciences, Inc. (CRBU) [Rocket]

In millions, except per share items	Jun-30-23	Mar-31-23	Dec-31-22	Sep-30-22	Mar-31-22	Dec-31-21	Sep-30-21	Jun-30-21
	10-Q	10-Q	10-K	10-Q	10-Q	10-K	10-Q	10-Q
Assets
Cash and equivalents	66.2	52.7	58.3	82.1	147.6	240.4	435.3	129.5
Short-term investments	193.0	175.8	189.3	211.3		135.4
Accounts receivable, net	0.8	1.5	0.2	0.4	0.4	1.2	0.6	0.0
Other current assets	8.5	9.4	12.4	13.2	220.0	14.2	13.2	13.4
Total current assets	268.5	239.5	260.2	306.9	368.0	391.2	449.0	143.0
Property, plant, and equipment, net	15.4	12.6	10.7	9.0	6.0	4.9	4.5	4.4
Long-term investments	33.3	62.5	69.4	49.2		37.7
Other fixed assets	1.4	1.5	1.5	1.3	1.5	1.0	0.8	3.4
Total assets	349.6	347.5	373.8	398.8	446.0	442.4	462.0	158.4

Accounts payable	4.4	2.7	1.1	1.2	1.8	4.0	3.5	4.0
Accrued expenses	16.2	12.6	16.2	14.7	11.3	13.1	13.9	13.3
Short-term debt	0.0	0.0	0.3	0.0	0.0	0.3	0.9	0.6
Short-term debt			0.3			0.3	0.9	0.6
Deferred revenues					0.1		0.1	0.1
Other current liabilities	13.7	11.8	10.5	12.8	13.5	8.4	7.8	8.1
Total current liabilities	34.4	27.1	28.1	28.8	26.7	25.8	26.2	26.0
Other liabilities	45.8	42.1	44.8	45.9	47.5	28.7	31.4	29.9
Total liabilities	80.2	69.2	72.9	74.7	74.2	54.5	57.6	55.9

Shareholders' equity [+]	269.5	278.3	300.9	324.1	371.8	387.8	404.4	102.5
Paid-in capital	525.4	504.3	499.6	496.4	489.8	485.7	483.7	10.6
Retained earnings	-254.8	-225.3	-197.2	-170.2	-116.9	-97.8	-79.3	-58.3
Tangible shareholders' equity	269.5	278.3	300.9	324.1	371.8	387.8	404.4	102.5